Hoth Therapeutics, Inc. (NASDAQ: HOTH) today announced a significant expansion of its CLEER-001 Phase 2a clinical trial with the addition of Regis Clinical Research as a new enrolling site. Located in ...
Earlier this month, health officials confirmed a fast-spreading outbreak in several North London schools, primarily affecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results